OFSI flags sanctions risks for art market participants and high value dealers
→Art and high-value goods firms must map OFSI reporting and licence-risk controls
OFSI
12 briefs
UK updates sanctions guidance for high value dealers and art market participants
→High value dealers must use the UK Sanctions List and £10,000 threshold
UK sanctions 3 entities and 9 individuals over Iranian hostile activity
→UK sanctions teams must block newly designated Iran-linked targets immediately
MHRA strengthens finasteride and dutasteride safety warnings
→UK prescribers must discuss updated finasteride and dutasteride safety risks
MHRA recalls Sertraline 100mg batch over packaging error
→Pharmacy teams must stop dispensing Sertraline batch V2500425 immediately
OFSI issues legal-services general licence for designated-person payments
→UK legal firms need INT/2026/9512597 terms before taking designated-person payments
MHRA orders Class 3 recall of Napralief 250mg batches
→Pharmacy supply teams must quarantine recalled Napralief batches now
MHRA recalls Ramipril 10mg batch over packaging error
→Dispensers must block Ramipril batch GR174091 from supply immediately
OFSI extends Interim Necessities General Licence to 22 October 2026
→Sanctions teams must retime licence controls to 22 October 2026 expiry
UK confirms British Industrial Competitiveness Scheme exemptions for eligible electricity bills from April 2027
→UK electricity suppliers must implement BICS eligibility verification and remove Renewables Obligation, Feed-in Tariff, and Capacity Market indirect-cost charges from eligible customers' bills before April 2027
UK approves single-dose 7.2mg Wegovy pen for obesity treatment
→Prescribers can administer full weekly dose in one injection
UK issues OFSI licence for Prince Group insolvency payments
→Payments allowed only if licence conditions are met